2-piperidone has been researched along with Carcinoma, Squamous Cell of Head and Neck in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chen, CW; Chen, YL; Hsieh, MJ; Hsieh, YH; Ju, PC; Lin, CW; Su, CW; Yang, SF | 1 |
da Fonseca, ACC; de Sousa, DP; Machado, TQ; Perez-Castillo, Y; Robbs, BK; Silva, RHN; Tejera, E | 1 |
Arrendale, RF; Chen, ZG; Culver, D; Evers, TJ; Fu, H; Howard, RB; Khuri, FR; Moore, TW; Morii, N; Reddy, P; Shin, DM; Shoji, M; Sica, G; Snyder, JP; Sun, A; Zhang, H; Zhu, S | 1 |
3 other study(ies) available for 2-piperidone and Carcinoma, Squamous Cell of Head and Neck
Article | Year |
---|---|
Curcumin analog HO-3867 triggers apoptotic pathways through activating JNK1/2 signalling in human oral squamous cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Curcumin; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Piperidones; Squamous Cell Carcinoma of Head and Neck | 2022 |
Molecular Modeling and In Vitro Evaluation of Piplartine Analogs against Oral Squamous Cell Carcinoma.
Topics: Cell Line, Tumor; Humans; Mouth Neoplasms; Piperidones; Quality of Life; Squamous Cell Carcinoma of Head and Neck | 2023 |
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Biological Availability; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Curcumin; Female; Half-Life; Head and Neck Neoplasms; Humans; I-kappa B Kinase; Mice, Inbred ICR; Mice, Nude; Neoplasm Proteins; Phosphorylation; Piperidones; Protein Processing, Post-Translational; Pyridines; Random Allocation; Specific Pathogen-Free Organisms; Squamous Cell Carcinoma of Head and Neck; Transcription Factor RelA; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |